Dov Elefant
2015 - Akari Therapeutics Plc
In 2015, Dov Elefant earned a total compensation of $1.1M as Chief Financial Officer at Akari Therapeutics Plc, a 397% increase compared to previous year.
Compensation breakdown
| Bonus | $37,500 |
|---|---|
| Option Awards | $857,879 |
| Salary | $200,000 |
| Total | $1,095,379 |
Elefant received $857.9K in option awards, accounting for 78% of the total pay in 2015.
Elefant also received $37.5K in bonus and $200K in salary.
Rankings
In 2015, Dov Elefant's compensation ranked 7,516th out of 13,638 executives tracked by ExecPay. In other words, Elefant earned more than 44.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,516 out of 13,638 | 45th |
Division Manufacturing | 2,840 out of 5,190 | 45th |
Major group Chemicals And Allied Products | 1,027 out of 1,854 | 45th |
Industry group Drugs | 828 out of 1,528 | 46th |
Industry Pharmaceutical Preparations | 650 out of 1,182 | 45th |
Source: SEC filing on April 28, 2016.
Elefant's colleagues
We found three more compensation records of executives who worked with Dov Elefant at Akari Therapeutics Plc in 2015.